NIDA Reissues International Collaborative Research Program Announcements
NIDA has reissued its Program Announcements (PAs) soliciting collaborative research proposals between investigators from domestic U.S. institutions and researchers in other countries. The PAs—International Research Collaboration on Drug Abuse and Addiction Research—will be in effect until May 8, 2018. Researchers may choose one of three grant programs in response to these broad calls for innovative research proposals:
- R01: PA-15-142
- R21: PA-15-143
- R03: PA-15-141.
Applications are encouraged in all areas of NIDA-supported science, including basic laboratory studies, clinical studies, epidemiological studies, community-based studies, and services research. Research priority areas include:
- Acute and chronic effects of marijuana, especially on the neurobiology and function of the brain, and the impacts of policies and laws regarding marijuana possession and use
- Linkages between HIV and drug use, especially seek, test, treat, and retain strategies to reach and test high-risk individuals and initiate and monitor highly active antiretroviral therapy for those who test positive
- The nature and extent of amphetamine-type stimulant abuse and synthetic and other designer drug abuse, their short- and long-term consequences, and prevention and treatment approaches
- Inhalant abuse, including epidemiological data, development and implementation of effective prevention programs, neurobiological impacts, and public awareness initiatives
- Prenatal impact of smoking and the effects on young people and adolescents of early exposure to tobacco, especially on cognitive development, progression to addiction, and development of other diseases
- Testing technologies to assess the prevalence of driving under the influence of drugs, the role of drugs in accidents, and the costs and benefits of laws and other programs to reduce the incidence and impact of drugged driving.
Get more information about the reissued program announcements.
International Program Director and Former NIDA Humphrey Fellows Join UNODC Informal International Scientific Network
Following a 2014 informal scientific consultation facilitated by NIDA Director Nora D. Volkow, M.D., and requests by United Nations member states, the United Nations Office on Drugs and Crime (UNODC) has created an Informal International Scientific Network to enhance collaboration between member states and scientists on the issues of drug use and addiction. NIDA International Program Director Steven W. Gust, Ph.D., and two former NIDA Hubert H. Humphrey Drug Abuse Research Fellows will serve on the panel and participated in the inaugural meeting of the network March 10–11, 2015, in Vienna, Austria. The former NIDA Humphrey fellows are Suzan Ben Ezra, who leads the Treatment and Rehabilitation Division of the Israeli Anti Drug Authority, and Jallal Toufiq, who directs the Moroccan National Centre on Drug Prevention, Treatment, and Research. The network will serve as a resource for UNODC, the Commission on Narcotic Drugs, and member states as they prepare for the 2016 United Nations General Assembly Special Session on the world drug problem. The Network members represent a wide range of drug abuse research disciplines and global regions.
Egyptian Version of NIDA National Drug Facts Week a Success
Egyptian drug abuse professionals participated in the January 2015 NIDA Drug Facts Week activities, holding events at schools, sporting clubs, youth centers, churches, the national police academy, and a book fair. Mohammed Elhamshary, M.D., M.Sc., 2014–2015 NIDA Hubert H. Humphrey Drug Abuse Research Fellow, coordinated an enthusiastic team of psychiatrists and social workers from Egypt Alabassiya Hospital to organize the events in collaboration with the country’s Mental Health Secretariat. The Egyptian experts used a NIDA online toolkit to help plan the event and disseminated free NIDA publications to teen participants. National Drug Facts Week provides teens with facts about the effects drugs have on the brain, body, and behavior. Since 2010, NIDA has supported school- and community-based events during National Drug Facts Week to counteract drug myths that teens get from the Internet, TV, movies, music, or friends. In 2015, more than 1,550 events were held throughout the world. Countries in Africa and Europe also participated in NIDA National Drug Facts Week. International educators, health professionals, and community organizations are invited to plan activities in their countries in conjunction with the 2016 National Drug Facts Week, which will be held January 25–31. For more information, visit the National Drug Facts Week website or email firstname.lastname@example.org.
NIDA, SAMHSA Host Humphrey Fellows
The 2014–2015 NIDA Hubert H. Humphrey Drug Abuse Research Fellows met with federal officials April 1 and 2 to learn about research priorities, initiatives, and resources offered by NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA). NIDA International Program Director Steven W. Gust, Ph.D., and Associate Director Dale Weiss hosted the fellows at NIDA. The following NIDA staff spoke with the fellows: Carmen Rosa, M.S., Center for the Clinical Trials Network; Cora Lee Wetherington, Ph.D., Division of Clinical Neuroscience and Behavioral Research; Richard A. Jenkins, Ph.D., Division of Epidemiology, Services and Prevention Research; and Geoffrey Laredo, M.P.A., and Maureen Boyle, Ph.D., Office of Science Policy and Communications. SAMHSA International Officer Winnie Mitchell hosted the fellows’ visit to that agency, where the fellows met with representatives from the Centers for Behavioral Health and Statistics and Quality, Mental Health Services, Substance Abuse Prevention, and Substance Abuse Treatment.
CTN Meeting Focuses on International Collaboration
Researchers from Australia, Canada, China, Ecuador, and Mexico briefed participants about their research during the international session at the NIDA Clinical Trials Network (CTN) Steering Committee Meeting. The meeting was held April 15–16, 2015, in Gaithersburg, Maryland. INVEST/CTN fellow Chandra Jha, Ph.D., Australia, discussed his study of factors related to relapse among former and relapsed Nepali drug users, and how public health strategies can minimize relapse risks. His fellowship mentor is Dennis Donovan, Ph.D., University of Washington. INVEST/CTN Fellow Haifeng Jiang, M.D., China, described his learning process as he works with his fellowship mentor to conduct secondary data analysis and design a clinical trial to be conducted in his home country. Dr. Jiang’s mentor is Walter Ling, M.D., University of California, Los Angeles. Zunyou Wu, M.D., Ph.D., director of the National Center for AIDS/STD Control & Prevention at the Chinese Center for Disease Control and Prevention, reported on the status of CTN-0056, a cluster randomized trial investigating whether two interventions will improve linkages between HIV testing and care for people living with HIV in China. Nathalie Gendron, Ph.D., assistant director of the Institute of Neurosciences, Mental Health and Addiction at the Canadian Institutes of Health Research, discussed the new Canadian Research Initiative in Substance Misuse, which uses the CTN model to create teams of university researchers and community-based treatment providers. Clinical Trials Unit Coordinator Rodrigo Marin-Navarrete, Ph.D., Instituto Nacional de Psiquiatria Ramón de la Fuente of Mexico, presented the results of a cross-sectional study of co-occurring disorders among patients in residential addiction treatment centers. Petra Jacobs, M.D., reported on substance abuse treatment and research in Ecuador. Dr. Jacobs is a former assistant director of the NIDA CTN and was a 2002 NIDA Distinguished International Scientist and a 2001–2001 NIDA Hubert H. Humphrey Drug Abuse Research Fellow.
INVEST/CTN Fellow Discusses Drug Abuse in Nepal
In a February 25, 2015, presentation for the University of Washington Nepal Speaker Series, Chandra K. Jha, Ph.D., reviewed relapse risks among Nepalese drug users and described evidence-based recommendations to provide drug detoxification and rehabilitation services in the country. A native of Nepal, Dr. Jha is an INVEST/CTN Drug Abuse Research Fellow working with University of Washington professor Dennis M. Donovan, Ph.D., at the Pacific Northwest Node of the NIDA Clinical Trials Network.
IPAS Adds Certificate Programs; Applications Due July 15
The International Programme in Addiction Studies (IPAS), a unique online collaboration of King’s College London, the University of Adelaide, and Virginia Commonwealth University, is now offering two graduate certificate programs in addiction studies in addition to its well-established master’s of science degree program. These certificates are designed for health care, social service, public health, or policy-focused professionals and graduate students who are seeking the latest in addiction-related knowledge but whose educational objectives do not include original research or a master’s-level credential. Options include a 12-credit Intermediate Certificate in International Addiction Studies and a 24-credit Advanced Certificate in International Addiction Studies. The 24-credit certificate is equivalent to a Graduate Diploma in Australia and the United Kingdom. Students successfully completing either certificate program may apply to the Master of Science in Addiction Studies Programme. Credits earned in the certificate programs may count toward the master’s degree. For more information about IPAS program options, curriculum, faculty, tuition, and application, visit the website at www.ipas.vcu.edu or email Mary Loos, Ph.D., at email@example.com. Applications will be accepted through July 15 for August 2015 enrollment. The online programs do not require campus attendance.
Save the Date! 2015 NIDA International Forum
Biltmore Hotel, Phoenix, Arizona
Online Registration Closes: May 1, 2015
InWomen’s 2015 Conference Announces Program, Seeks Entries for Annotated Bibliography
Biltmore Hotel, Phoenix, Arizona
For more information, visit inwomen health or contact InWomen’s Chair Wendee Wechsberg, Ph.D., at firstname.lastname@example.org.
The eighth International Women’s and Children’s Health and Gender Group Conference will feature a poster session, two panel discussions, discussion tables, and cultural events. The panelists will discuss: (1) reproductive health through the lifespan and (2) young women and adolescents. An annotated bibliography will record recent publications that focus on gender differences, women, children, or adolescents and substance use, abuse, treatment, or prevention. Submit publications to the 2015 InWomen Annotated Bibliography at http://goo.gl/forms/qi1pGlqvOY. Registration for the conference is $200; a reduced fee of $100 is available for students and registrants from low-income countries.